Gene · 4821
NIH grants1,452
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 1,452
Download this page as JSON| Grant | Title | NKX2-2 papers | Newest fiscal year |
|---|---|---|---|
| P01HD076892 | Alexander disease: mechanisms, modifiers, and therapeutics | 1 | 2018 |
| P30DK041296 | Liver Pathobiology and Gene Therapy Research Core Center | 1 | 2018 |
| R00HG008171 | Genome engineering tools for functional screening of non-coding elements | 1 | 2018 |
| R00MH102357 | Genetic Influences on Human Cortical Development | 1 | 2018 |
| R01AR066124 | Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton | 1 | 2018 |
| R01CA181648 | VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis | 1 | 2018 |
| R01DA035804 | Genetics and Progression of Early-onset Substance Dependence and HIV Risk | 1 | 2018 |
| R01DA037618 | Functions of D4 Dopamine Receptors in Prefrontal Cortex | 1 | 2018 |
| R01DK099734 | EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITS | 1 | 2018 |
| R01DK101478 | Algorithms to identify non-coding mutational burden and disease-relevant pathways | 1 | 2018 |
| R01DK103215 | Role of SerpinB1 in beta cell growth | 1 | 2018 |
| R01DK107412 | Pax4-induced alpha-to-beta cell conversion | 1 | 2018 |
| R01ES016931 | Gene-Neurotoxicant Interactions in Huntington Disease | 1 | 2018 |
| R01GM043901 | Maintenance of Gene Expression | 1 | 2018 |
| R01GM104853 | Control of collective cell movement by planar cell polarity signaling | 1 | 2018 |
| R01GM112720 | Mechanisms of enhancer activation in early development | 1 | 2018 |
| R01GM114276 | Centriolar-ciliary signaling mechanisms in tissue regeneration and differentiation | 1 | 2018 |
| R01HG007538 | Computational and Experimental Modeling of Epigenetic DNA Methylation | 1 | 2018 |
| R01HL074185 | Reversing diabetic muscle myopathy by exercise and exosomes | 1 | 2018 |
| R01HL093009 | Mediators of Atherosclerosis in South Asians Living in America | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/grants?page=36